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LETTER
A GWAS meta-analysis
suggests roles for xenobiotic
metabolism and ion channel
activity in the biology of stool
frequency
Stool consistency and frequency patterns are
complex traits that are often altered in GI
disease, and recent studies published in Gut
highlight the importance of stool frequency
in relation to gut microbiota composition
and the efﬁcacy of pharmacological and
dietary treatments in IBS.1–3
Despite reported heritability in
invertebrates4 and similar evidence from
open-ﬁeld defaecation models in rats,5 the
genetics of stool frequency has not been
explored in humans. We undertook a
genome-wide association study (GWAS) in
two well-characterised population-based
cohorts with genotype and defaecation data
available: LifeLines-Deep (LLD) from the
Netherlands (N=1546; 58% females; mean
age 44 years (range 18–86)) and PopCol
(PC) from Sweden (N=284; 60% females;
mean age 54 years (range 22–71)).6 7 The
average number of bowel movements per
day (BM/d) was extracted from daily
records kept by both populations and did
not differ between cohorts (LLD=1.39
±0.64SD; PC=1.42±0.74SD). Available
CytoChip+Immunochip (LLD) and
HumanOmniExpressExome (PC) Illumina
single-nucleotide polymorphism (SNP)
genotype data were imputed using
IMPUTE2 (https://mathgen.stats.ox.ac.uk/
impute/impute_v2.html) with the Genome
of the Netherlands (http://www.nlgenome.
nl/) as reference. SNPs were ﬁltered on
minor allele frequency >0.05 and Hardy–
Weinberg equilibrium p>1E-04, samples
were ﬁltered on infoscore ≥0.8 and popula-
tion outliers were excluded using principal
component analysis. In total, high-quality
genotype data for 5 390 800 common SNPs
and BM/d information were obtained
for 1022 LLD and 259 PC individuals.
Figure 1 Manhattan plot of the results from the meta-analysis of LifeLines-Deep (LLD) and PopCol (PC) genome-wide association studies.
Single-nucleotide polymorphisms (SNPs) which are sorted according to their genomic positions are displayed on the X-axis, and the negative
logarithm of the association p value for each SNP after meta-analysis is displayed on the Y-axis; each dot represents a SNP with a certain p value.
The top-10 loci are indicated by numbers. Per locus, the statistics of the lead SNPs are shown, including the positions in the genome, the nearest
genes and the genes in a 250 kb window around the lead SNPs. The effect of the assessed allele at each locus is indicated by beta; negative betas
mean negative effect on the average number of bowel movements per day (BM/d) (decreased number of stool passes) and positive betas mean
positive effect on the average number of BM/d (increased number of stool passes). Beta, direction of association; BP, base pair position;
Chr, chromosome; SE, SE of the beta.
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Genotype–BM/d association tests were per-
formed in SNPTEST (https://mathgen.
stats.ox.ac.uk/genetics_software/snptest/
snptest.html) using logistic regression
under an additive model correcting for age
and sex, followed by a ﬁxed-effect model
meta-analysis with META (https://
mathgen.stats.ox.ac.uk/genetics_software/
meta/meta.html). Summary statistics for
the top-10 loci from the meta-analysis and
the corresponding effect of associated alleles
on the frequency (increased/decreased) of
defaecation are given in ﬁgure 1.
Although none of these associations
achieved genome-wide signiﬁcance (pos-
sibly due to limited sample size), we
found excellent functional candidates
mapping to these regions. For instance,
the second strongest signal included the
ALDH1A1 gene, which belongs to the
family of aldehyde dehydrogenases, and
another member of this family
(ALDH1AL1) has been shown to affect
human gut microbiota composition.8
Moreover, Gene Network coexpression
analysis (http://www.genenetwork.nl/
genenetwork/) indicated a role for
ALDH1A1 in the cytochrome P450
metabolism of drugs and xenobiotics, and
other genes in this pathway also map to
top BM/d GWAS loci: the rs735320 signal
comes from SNPs in the CYP8B1 gene,
which belongs to the cytochrome P450
family; the rs4090 286 locus contains
CYB5R2 (cytochrome B5 reductase),
which is involved in cholesterol biosyn-
thesis, fatty acid desaturation and elong-
ation; and the rs1979097 locus contains
AHR (ligand-activated aryl hydrocarbon
receptor), which is a transcription factor
modulating gene expression along the
cytochrome P450 pathway. The genetic
implication of xenobiotic and P450
metabolic pathways is not unexpected,
given the interactions linking diet, gut
microbiome and pharmaceutical com-
pounds to known effects on human defae-
cation patterns, but was not reported
previously.
A broader pathway analysis (http://129.
125.135.180:8080/GeneNetwork/pathway.
html), including genes from all 53 loci with
p<5E-05, identiﬁed the sodium channel
complex and voltage-gated sodium channel
activity as the most enriched pathways in
Gene Ontology (GO) terms for cellular
component and molecular function,
respectively (table 1). This is remarkable,
since genetic defects in the voltage-gated
channel SCN5A have been found in a
subset of patients with IBS, and normal
stool frequency was restored in a severely
constipated SCN5A mutant carrier treated
with mexiletine, a drug able to rescue
SCN5A expression.9
In conclusion, we report the ﬁrst GWAS
of stool frequency in two harmonised
population-based cohorts from the
Netherlands and Sweden and highlight
plausible candidate genes and biological
pathways. Although we are not aware of
similar datasets in which our ﬁndings may
be replicated, the growing interest in this
research area warrants larger studies to
reach unequivocal conclusions.
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